|
82
|
296
|
2v22A |
Replace: a strategy for iterative design of cyclin binding groove inhibitors |
|
78
|
298
|
2v0dA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
87
|
296
|
2uzeA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
108
|
337
|
2uvxA |
Structure of pka-pkb chimera complexed with 7-azaindole |
|
93
|
316
|
2v62A |
Structure of vaccinia-related kinase 2 |
|
108
|
336
|
2uzvA |
Pka structures of indazole-pyridine series of akt inhibitors |
|
76
|
296
|
2uzoA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
109
|
337
|
2uw7A |
Structure of pka-pkb chimera complexed with 4-(4-chloro-phenyl)-4-(4- (1h-pyrazol-4-yl)-phenyl)-piperidine |
|
90
|
399
|
2v55A |
Mechanism of multi-site phosphorylation from a rock-i:rhoe complex structure |
|
111
|
336
|
2uztA |
Pka structures of akt, indazole-pyridine inhibitors |
|
88
|
296
|
2uzdA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
83
|
285
|
2v5qA |
Crystal structure of wild-type plk-1 kinase domain in complex with a selective darpin |
|
75
|
298
|
2uznA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
90
|
269
|
2vgpA |
Crystal structure of aurora b kinase in complex with a aminothiazole inhibitor |
|
100
|
336
|
2uzwE |
Pka structures of indazole-pyridine series of akt inhibitors |
|
80
|
296
|
2uzbA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
107
|
337
|
2uw8A |
Structure of pka-pkb chimera complexed with 2-(4-chloro-phenyl)-2- phenyl-ethylamine |
|
104
|
337
|
2uw4A |
Structure of pka-pkb chimera complexed with 2-(4-(5-methyl-1h-pyrazol- 4-yl)-phenyl)-ethylamine |
|
102
|
307
|
2v7oA |
Crystal structure of human calcium-calmodulin-dependent protein kinase ii gamma |
|
106
|
337
|
2uw3A |
Structure of pka-pkb chimera complexed with 5-methyl-4-phenyl-1h- pyrazole |
|
87
|
288
|
2uv2A |
Crystal structure of human ste20-like kinase bound to 4-(4-(5- cyclopropyl-1h-pyrazol-3-ylamino)-quinazolin-2-ylamino)-phenyl)- acetonitrile |
|
71
|
316
|
2rfdA |
Crystal structure of the complex between the egfr kinase domain and a mig6 peptide |
|
83
|
294
|
2rkuA |
Structure of plk1 in complex with bi2536 |
|
84
|
296
|
2uzlA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
108
|
337
|
2uvzA |
Structure of pka-pkb chimera complexed with c-phenyl-c-(4-(9h-purin-6- yl)-phenyl)-methylamine |
|
60
|
403
|
2rsvA |
Solution structure of human full-length vaccinia related kinase 1 (vrk1) |
|
106
|
336
|
2uzuE |
Pka structures of indazole-pyridine series of akt inhibitors |
|
104
|
337
|
2uw6A |
Structure of pka-pkb chimera complexed with (s)-2-(4-chloro-phenyl)- 2-(4-1h-pyrazol-4-yl)-phenyl)-ethylamine |
|
81
|
296
|
2uueA |
Replace: a strategy for iterative design of cyclin binding groove inhibitors |
|
114
|
427
|
2rioA |
Structure of the dual enzyme ire1 reveals the basis for catalysis and regulation of non-conventional splicing |
|
81
|
270
|
2v7aA |
Crystal structure of the t315i abl mutant in complex with the inhibitor pha-739358 |
|
96
|
356
|
2r9sA |
C-jun n-terminal kinase 3 with 3,5-disubstituted quinoline inhibitor |
|
99
|
311
|
2rl5A |
Crystal structure of the vegfr2 kinase domain in complex with a 2,3-dihydro-1,4-benzoxazine inhibitor |
|
108
|
336
|
2uvyA |
Structure of pka-pkb chimera complexed with methyl-(4-(9h-purin-6-yl)- benzyl)-amine |
|
134
|
450
|
2srcA |
Crystal structure of human tyrosine-protein kinase c-src, in complex with amp-pnp |
|
85
|
295
|
2rfnA |
X-ray structure of c-met with inhibitor. |
|
85
|
296
|
2reiA |
Kinase domain of human ephrin type-a receptor 7 (epha7) |
|
107
|
336
|
2uw5A |
Structure of pka-pkb chimera complexed with (r)-2-(4-chloro-phenyl)- 2-(4-1h-pyrazol-4-yl)-phenyl)-ethylamine |
|
102
|
329
|
2r7iA |
Crystal structure of catalytic subunit of protein kinase ck2 |
|
93
|
337
|
2uw9A |
Structure of pkb-beta (akt2) complexed with 4-(4-chloro-phenyl)-4-(4-(1h-pyrazol-4-yl)-phenyl)-piperidine |
|
104
|
348
|
2rg5A |
Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11b |
|
81
|
298
|
2r3mA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
79
|
279
|
2r0uA |
Crystal structure of chek1 in complex with inhibitor 54 |
|
110
|
349
|
2rg6A |
Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11j |
|
65
|
285
|
2rf9A |
Crystal structure of the complex between the egfr kinase domain and a mig6 peptide |
|
79
|
280
|
2rfsA |
X-ray structure of su11274 bound to c-met |
|
82
|
285
|
2r7bA |
Crystal structure of the phosphoinositide-dependent kinase-1 (pdk-1)catalytic domain bound to a dibenzonaphthyridine inhibitor |
|
84
|
285
|
2r2pA |
Kinase domain of human ephrin type-a receptor 5 (epha5) |
|
83
|
298
|
2r3nA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
85
|
315
|
2rgpA |
Structure of egfr in complex with hydrazone, a potent dual inhibitor |
